New cancer clinical trial: Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer

Published on: November 30, 2017 at 10:00AM
Condition:   Triple Negative Breast Cancer
Interventions:   Drug: Zoledronate;   Drug: Atorvastatin 80mg;   Drug: Standard neoadjuvant cht
Sponsors:   Mario Negri Institute for Pharmacological Research;   Associazione Italiana per la Ricerca sul Cancro
Not yet recruiting
http://ift.tt/2zPs6J3